|
| 1 |
The cutting-edge technologies of siRNA delivery and their application in clinical trials
Lee, Kyuri;Jang, Bora;Lee, You-ri;Suh, Eun-young;Yoo, Ji-seon;Lee, Mi-jin;Lee, Joo-young;Lee, Hyukjin;
/
The Pharmaceutical Society of Korea
, v.41, no.9, pp.867-874,
|
|
| 2 |
High-throughput genetic screens using CRISPR-Cas9 system
Kweon, Jiyeon;Kim, Yongsub;
/
The Pharmaceutical Society of Korea
, v.41, no.9, pp.875-884,
|
|
| 3 |
Generation of genetically-engineered animals using engineered endonucleases
Lee, Jong Geol;Sung, Young Hoon;Baek, In-Jeoung;
/
The Pharmaceutical Society of Korea
, v.41, no.9, pp.885-897,
|
|
| 4 |
In vivo genome editing targeted towards the female reproductive system
Sato, Masahiro;Ohtsuka, Masato;Nakamura, Shingo;Sakurai, Takayuki;Watanabe, Satoshi;Gurumurthy, Channabasavaiah B.;
/
The Pharmaceutical Society of Korea
, v.41, no.9, pp.898-910,
|
|
| 5 |
Efficient genome editing by FACS enrichment of paired D10A Cas9 nickases coupled with fluorescent proteins
Gopalappa, Ramu;Song, Myungjae;Chandrasekaran, Arun Pandian;Das, Soumyadip;Haq, Saba;Koh, Hyun Chul;Ramakrishna, Suresh;
/
The Pharmaceutical Society of Korea
, v.41, no.9, pp.911-920,
|
|
| 6 |
CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes
Byeon, Ji-Young;Kim, Young-Hoon;Lee, Choong-Min;Kim, Se-Hyung;Chae, Won-Ki;Jung, Eui-Hyun;Choi, Chang-Ik;Jang, Choon-Gon;Lee, Seok-Yong;Bae, Jung-Woo;Lee, Yun Jeong;
/
The Pharmaceutical Society of Korea
, v.41, no.9, pp.921-930,
|
|
| 7 |
The influences of CYP2C9*1/*3 genotype on the pharmacokinetics of zolpidem
Byeon, Ji-Yeong;Kim, Young-Hoon;Kim, Se-Hyung;Lee, Choong-Min;Jung, Eui-Hyun;Chae, Won-Ki;Jang, Choon-Gon;Lee, Seok-Yong;Lee, Yun Jeong;
/
The Pharmaceutical Society of Korea
, v.41, no.9, pp.931-936,
|
|